High oral corticosteroid exposure and overuse of short-acting beta-2-agonists were associated with insufficient prescribing of controller medication: a nationwide electronic prescribing and dispensing database analysis

Table 2 The 1-year combinations of classes of medication prescribed to the 8798 patients on PRT

Maintenance treatment prescribed	PRT with high OCS exposure (n = 186)		PRT
Maintenance treatment prescribed	n	%	n	%
ICS + LABA	61	32.8	3113	35.4
ICS + LABA + LAMA	46	24.7	1008	11.5
ICS + LTRA + LABA + LAMA	21	11.3	355	4.0
ICS + LABA + LTRA	15	8.1	1204	13.7
LABA + LAMA	13	7.0	635	7.2
ICS monotherapy	8	4.3	310	3.5
LTRA monotherapy	6	3.2	916	10.4
LABA monotherapy	5	2.7	340	3.9
ICS + LAMA	3	1.6	143	1.6
LAMA monotherapy	3	1.6	476	5.4
ICS + LTRA	2	1.1	126	1.4
LTRA + LABA	1	0.5	50	0.6
LTRA + LAMA	1	0.5	41	0.5
ICS + LTRA + LAMA	1	0.5	22	0.3
LTRA + LABA + LAMA	0	0.0	59	0.7

PRT persistent respiratory treatment, SABA short-acting beta2 agonist, OCS oral corticosteroids, ICS inhaled corticosteroids, LABA long-acting beta2 agonists, LTRA leukotriene receptors antagonists, LAMA long-acting muscarinic antagonist

ISSN: 2045-7022